CME: Preventing group B streptococcal infections with targeted therapy
March 1st 2001Since the CDC recommendations have been put into practice, we've seen a dramatic decline in early-onset neonatal GBS infections. But an expert in the field discusses several unresolved issues and emphasizes the need for continued vigilance to keep the disease under control.
New developments in maternal fetal medicine
March 1st 2001The 2001 annual meeting of the Society for Maternal-Fetal Medicine offered a wide array of important research findings--and new clinical implications--on tocolysis, thrombophilia, cerclage, antenatal steroid therapy, and group B streptocccal infection.
Symposium: Strategies to prevent multiple pregnancy during infertility treatment
February 1st 2001Pregnancies from assisted reproductive technology or ovulation induction are more likely to result in multiple birth than those conceived spontaneously. In this roundtable, a panel of experts discusses practical strategies to increase the likelihood that ART and OI/IUI will result in a singleton pregnancy.
CME: Offering mifepristone as an abortion option
February 1st 2001While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug need to familiarize themselves with the research on its advantages and disadvantages.
Cover Story: Antepartum and intrapartum risk factors for newborn encephalopathy
February 1st 2001Many obstetric malpractice cases focus on fixing the blame for disturbed neurological function in the first days of an infant's life. Results of recent case-control studies, described here by the authors, question the traditional thinking that most of the risk factors are in the intrapartum period.